W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; SYSTEM, ENDO GRAFT, ARTERIOVENOUS DIALYSIS ACCESS CIRCUIT STENOSIS TREATMENT
|
Back to Search Results |
|
Catalog Number JHJR061002J |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Obstruction/Occlusion (2422)
|
Event Date 01/18/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
On (b)(6) , 2021, this patient underwent endovascular procedure to treat a venous anastomosis stenosis of an arteriovenous graft located in the basilic vein in the right upper arm using a gore® viabahn® endoprosthesis with heparin bioactive surface.The patient tolerated the procedure.On (b)(6) , 2021, it was observed that the endoprosthesis was occluded with thrombus.On (b)(6) , 2021, a re-intervention was performed to treat the occluded endoprosthesis.Balloon dilatation and thrombolysis were reportedly performed.The event was resolved, and the patient tolerated the procedure.
|
|
Manufacturer Narrative
|
A review of the manufacturing records, including manufacturing, heparin coatings, and sterilization, indicated the device met pre-release specifications.Section h6: investigation findings: was updated to code 213 to reflect this information.G3 corrected to "yes" for combination product.
|
|
Manufacturer Narrative
|
G4: pma/510k number field corrected from p040037 to p130006.
|
|
Search Alerts/Recalls
|
|
|